| 1 | artery smooth muscle contraction (GO:0014824) | 6.86956554 |
| 2 | tonic smooth muscle contraction (GO:0014820) | 5.98110855 |
| 3 | positive regulation of actin filament depolymerization (GO:0030836) | 5.50374948 |
| 4 | energy homeostasis (GO:0097009) | 5.38142899 |
| 5 | mitotic nuclear envelope reassembly (GO:0007084) | 5.32078466 |
| 6 | nuclear envelope reassembly (GO:0031468) | 5.32078466 |
| 7 | protein maturation by protein folding (GO:0022417) | 5.29589320 |
| 8 | proteasome assembly (GO:0043248) | 4.58776837 |
| 9 | inositol phosphate-mediated signaling (GO:0048016) | 4.26059222 |
| 10 | prostaglandin biosynthetic process (GO:0001516) | 4.09139932 |
| 11 | prostanoid biosynthetic process (GO:0046457) | 4.09139932 |
| 12 | type B pancreatic cell proliferation (GO:0044342) | 4.07090806 |
| 13 | positive regulation of glycoprotein metabolic process (GO:1903020) | 4.04233330 |
| 14 | GDP-mannose metabolic process (GO:0019673) | 4.02598105 |
| 15 | nucleotide-sugar biosynthetic process (GO:0009226) | 4.02087124 |
| 16 | establishment of integrated proviral latency (GO:0075713) | 3.92919811 |
| 17 | COPI coating of Golgi vesicle (GO:0048205) | 3.88731030 |
| 18 | Golgi transport vesicle coating (GO:0048200) | 3.88731030 |
| 19 | protein retention in ER lumen (GO:0006621) | 3.86606739 |
| 20 | daunorubicin metabolic process (GO:0044597) | 3.86217684 |
| 21 | polyketide metabolic process (GO:0030638) | 3.86217684 |
| 22 | doxorubicin metabolic process (GO:0044598) | 3.86217684 |
| 23 | establishment of viral latency (GO:0019043) | 3.84592547 |
| 24 | hepatocyte apoptotic process (GO:0097284) | 3.76310158 |
| 25 | inner mitochondrial membrane organization (GO:0007007) | 3.68333068 |
| 26 | nucleoside transport (GO:0015858) | 3.67047118 |
| 27 | autophagic vacuole fusion (GO:0000046) | 3.65338488 |
| 28 | ganglion development (GO:0061548) | 3.63100517 |
| 29 | endothelial tube morphogenesis (GO:0061154) | 3.60781804 |
| 30 | morphogenesis of an endothelium (GO:0003159) | 3.60781804 |
| 31 | vascular smooth muscle contraction (GO:0014829) | 3.59580319 |
| 32 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.55760069 |
| 33 | negative regulation of mitochondrion organization (GO:0010823) | 3.54271806 |
| 34 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.48471107 |
| 35 | nucleoside transmembrane transport (GO:1901642) | 3.46947446 |
| 36 | interferon-gamma secretion (GO:0072643) | 3.45878686 |
| 37 | regulation of metalloenzyme activity (GO:0048552) | 3.43531017 |
| 38 | regulation of mitochondrial translation (GO:0070129) | 3.43074501 |
| 39 | prostaglandin metabolic process (GO:0006693) | 3.40574410 |
| 40 | prostanoid metabolic process (GO:0006692) | 3.40574410 |
| 41 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.38456759 |
| 42 | chaperone-mediated protein transport (GO:0072321) | 3.38311739 |
| 43 | organelle membrane fusion (GO:0090174) | 3.36353813 |
| 44 | positive regulation of heart rate (GO:0010460) | 3.32047357 |
| 45 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.29871755 |
| 46 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.26121737 |
| 47 | desmosome organization (GO:0002934) | 3.24387934 |
| 48 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.23915459 |
| 49 | ribosome assembly (GO:0042255) | 3.19761594 |
| 50 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.19510491 |
| 51 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.14502458 |
| 52 | positive regulation of growth hormone secretion (GO:0060124) | 3.12537241 |
| 53 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.12315275 |
| 54 | phasic smooth muscle contraction (GO:0014821) | 3.09079937 |
| 55 | purine ribonucleotide transport (GO:0015868) | 3.05576135 |
| 56 | positive regulation of protein depolymerization (GO:1901881) | 2.98257180 |
| 57 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.98000473 |
| 58 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.96324359 |
| 59 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.94109641 |
| 60 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.92596682 |
| 61 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.92223894 |
| 62 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.92223894 |
| 63 | muscle cell migration (GO:0014812) | 2.91399069 |
| 64 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.90801164 |
| 65 | protein localization to endosome (GO:0036010) | 2.88271475 |
| 66 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.86806969 |
| 67 | glycoside metabolic process (GO:0016137) | 2.85197084 |
| 68 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.82563037 |
| 69 | cobalamin metabolic process (GO:0009235) | 2.77388926 |
| 70 | protein deneddylation (GO:0000338) | 2.76608167 |
| 71 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.76177963 |
| 72 | negative regulation of ligase activity (GO:0051352) | 2.76177963 |
| 73 | cullin deneddylation (GO:0010388) | 2.75425735 |
| 74 | lung secretory cell differentiation (GO:0061140) | 2.74395379 |
| 75 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.74208449 |
| 76 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.73237528 |
| 77 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.70938184 |
| 78 | activation of Rac GTPase activity (GO:0032863) | 2.69614440 |
| 79 | negative regulation of glycogen metabolic process (GO:0070874) | 2.69355727 |
| 80 | actin filament depolymerization (GO:0030042) | 2.69058622 |
| 81 | mesonephros development (GO:0001823) | 2.68729219 |
| 82 | xenobiotic catabolic process (GO:0042178) | 2.68438615 |
| 83 | regulation of cellular respiration (GO:0043457) | 2.67451017 |
| 84 | positive regulation of heart contraction (GO:0045823) | 2.66341376 |
| 85 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.64612952 |
| 86 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.63292584 |
| 87 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.63292584 |
| 88 | pattern specification involved in kidney development (GO:0061004) | 2.63013271 |
| 89 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.61670187 |
| 90 | protein hydroxylation (GO:0018126) | 2.61488799 |
| 91 | extracellular fibril organization (GO:0043206) | 2.61009640 |
| 92 | nucleoside salvage (GO:0043174) | 2.60631540 |
| 93 | positive regulation of ligase activity (GO:0051351) | 2.59793363 |
| 94 | adenine nucleotide transport (GO:0051503) | 2.59022812 |
| 95 | glutathione derivative biosynthetic process (GO:1901687) | 2.58941338 |
| 96 | glutathione derivative metabolic process (GO:1901685) | 2.58941338 |
| 97 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.58679817 |
| 98 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.58679817 |
| 99 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.58679817 |
| 100 | endocardial cushion development (GO:0003197) | 2.56261992 |
KRT8P5 
